Scaling Fusion for Global Impact

July has been a significant month for Astral Systems as we continue to advance the development and deployment of compact fusion technology.

From industry recognition at The SPARKies 2026 to continued engagement with global research communities, Astral is building the technology, partnerships and capabilities required to unlock the potential of fusion-enabled solutions across healthcare, industry, and energy.

External Validation: Recognised Engineering and Investment Momentum

Astral Systems has been recognised with two major accolades at The SPARKies 2026, winning Engineering Product / Business of the Year and Most Exciting Investment Deal.

The recognition reflects two important milestones in Astral’s journey: the strength of our engineering platform and growing confidence in the commercial potential of our technology.

The judges highlighted our technical innovation, international market opportunity and our £23 million Series A funding round as key factors behind the awards.

For a deep tech company, turning scientific innovation into real-world impact requires both technical excellence and the ability to execute. This recognition reflects the commitment of our team, the confidence of our investors and the support of our partners as we continue to develop and scale our technology.

Our focus remains firmly on execution, expanding our capabilities and advancing solutions that address critical challenges across healthcare, industry and energy.

Advancing Fusion Research: Astral Featured in Channel NewsAsia Documentary

Astral was recently featured in Channel NewsAsia’s latest documentary exploring the future of nuclear energy and the technologies shaping the next generation of fusion.

The segment highlights one of fusion’s most significant challenges: developing a sustainable tritium fuel cycle.

As fusion moves closer towards commercial deployment, access to experimental platforms that generate high quality research data will be essential to advancing understanding of future fusion systems. Astral’s compact fusion reactors provide a flexible platform for fusion research, with applications spanning tritium breeding studies, radioisotope production, materials testing and industrial diagnostics.

The research featured in the documentary is being conducted in collaboration with the University of Bristol and funded by UKAEA, demonstrating the role Astral’s technology can play in supporting the development of future fusion power solutions.

Watch the CNA segment from 27:00

Expanding Irradiation Capabilities for Global Research and Industry

As Astral continues to expand its irradiation services, engagement with the international radiation community remains an important part of understanding industry needs and developing our capabilities.

Our Chief Executive Officer and senior team recently attended the IEEE Nuclear and Space Radiation Effects Conference (NSREC), connecting with researchers, engineers and industry leaders working across radiation science, space, defence and advanced electronics.

These discussions continue to reinforce the importance of accessible neutron irradiation capabilities for organisations developing and testing next generation technologies.

Astral’s neutron irradiation facilities support a growing range of applications, including nuclear materials testing, industrial diagnostics and medical isotope research. With increasing demand for irradiation services, our facilities provide researchers and industry partners with a flexible platform to support testing, development and qualification programmes.

To discuss your irradiation requirements, contact our team at: https://www.astralsystems.com/neutron-services